Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Change in Receivables: 2020-2024

Historic Change in Receivables for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to -$4.5 million.

  • Journey Medical's Change in Receivables rose 175.37% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year increase of 98.23%. This contributed to the annual value of -$4.5 million for FY2024, which is 64.35% up from last year.
  • According to the latest figures from FY2024, Journey Medical's Change in Receivables is -$4.5 million, which was up 64.35% from -$12.6 million recorded in FY2023.
  • Over the past 5 years, Journey Medical's Change in Receivables peaked at $5.4 million during FY2022, and registered a low of -$12.6 million during FY2023.
  • In the last 3 years, Journey Medical's Change in Receivables had a median value of -$4.5 million in 2024 and averaged -$3.9 million.
  • Its Change in Receivables has fluctuated over the past 5 years, first surged by 800.52% in 2022, then tumbled by 333.29% in 2023.
  • Over the past 5 years, Journey Medical's Change in Receivables (Yearly) stood at $5.0 million in 2020, then crashed by 115.29% to -$768,000 in 2021, then soared by 800.52% to $5.4 million in 2022, then plummeted by 333.29% to -$12.6 million in 2023, then surged by 64.35% to -$4.5 million in 2024.